Biotech Leader Faces Key Resistance Test

Published 11/02/2015, 11:21 AM
Updated 07/09/2023, 06:31 AM
US500
-
IBB
-

iShares Nasdaq Biotechnology

A month ago the S&P 500 created the largest reversal pattern (bullish wick) since THE low in 2011. We shared this reversal pattern with our members the following morning.

What followed that reversal was almost historic, as the S&P 500 had its best month in four years and its 6th best October EVER.

October is now behind us, what's important to watch next?

In our humble opinion, leadership remains a must monitor. Today we look at Biotech ETF (O:IBB), which has been in the leadership role since the 2011 lows. IBB fell harder during the summer softness and rallied over the past month along with the broad markets.

The rally now has IBB facing its 38% retracement level and falling resistance, based on weekly closing prices at (1) above.

What this leader does at (1) could tell us a ton about where the S&P is at year's end.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.